PAPER Rajput A, Rajput AH, Rajput ML, Encarnacion M, Bernales CQ, Ross JP, Farrer MJ, Vilariño-Güell C
SEARCH RESULTS
332218 RESULTS
PAPER Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S, Suyama S, Kuwako K, Imai T, Murayama S, Suzuki N, Okano H
The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.
Mol Brain. 2013;6:31. PubMed.PAPER Lilo E, Wald-Altman S, Solmesky LJ, Ben Yaakov K, Gershoni-Emek N, Bulvik S, Kassis I, Karussis D, Perlson E, Weil M
Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse model.
Hum Mol Genet. 2013 Jul 23; PubMed.AD Trial Simulation Tool Receives Regulators’ Blessings
RESEARCH NEWS 2013-07-11 Research News Regulatory agencies in the U.S. and Europe have endorsed a quantitative simulation tool that allows researchers to model clinical trials in mild to moderate Alzheimer’s disease. The freely available tool will allow researchers to optimize th
PAPER
Medicine: Stem cells guide Alzheimer's drugs.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Mar;29(2):116-8, 127. PubMed.PAPER Li YL, Hou Y, Niu C, Yu LX, Cheng YY, Hong Y
[The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Mar;29(2):116-8, 127. PubMed.PAPER Chakrabarti S, Sinha M, Thakurta IG, Banerjee P, Chattopadhyay M
Oxidative Stress and Amyloid Beta Toxicity in Alzheimer's Disease: Intervention in a Complex Relationship by Antioxidants.
Curr Med Chem. 2013 Jun 25; PubMed.PAPER Weinstein JD, Gonzalez ER, Egleton RD, Hunt DA
A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol.
Consult Pharm. 2013 Jul;28(7):443-54. PubMed.PAPER Chmielnicki E
Alzheimer's disease: Micrological modulation.
Nat Med. 2013 Jul;19(7):826. PubMed.PAPER Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, Saso L
Antioxidant Activity of Galantamine and some of its Derivatives.
Curr Med Chem. 2013 Jun 25; PubMed.PAPER Andrieux K, Couvreur P
Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
Ann Pharm Fr. 2013 Jul;71(4):225-33. PubMed.PAPER Dartigues JF, Foubert-Samier A, Helmer C
[Relationship between educational level and dementia: Social factor and age-related chronic disease].
Rev Epidemiol Sante Publique. 2013 Aug;61 Suppl 3:S195-8. PubMed.PAPER Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L
Seizures and epileptiform activity in the early stages of Alzheimer disease.
JAMA Neurol. 2013 Sep 1;70(9):1158-66. PubMed.PAPER Kingwell K
Alzheimer disease: CSF levels of mitochondrial DNA-a new biomarker for preclinical Alzheimer disease?
Nat Rev Neurol. 2013 Aug;9(8):420. PubMed.PAPER Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA
Genetic susceptibility for Alzheimer disease neuritic plaque pathology.
JAMA Neurol. 2013 Sep 1;70(9):1150-7. PubMed.Current Filters
No filters selected